{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:01:52Z","timestamp":1788476512030,"version":"build-2803163510"},"reference-count":86,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T00:00:00Z","timestamp":1479081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.vaccine.2016.10.078","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T10:01:25Z","timestamp":1479895285000},"page":"6691-6699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"title":["Vaccine strategies: Optimising outcomes"],"prefix":"10.1016","volume":"34","author":[{"given":"Karin","family":"Hardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ignacio","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"El-Hodhod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Zimet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Preiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.10.078_b0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/BF03391594","article-title":"Communicable diseases: achievements and challenges for public health","volume":"32","author":"Schlipk\u00f6ter","year":"2010","journal-title":"Public Health Rev"},{"key":"10.1016\/j.vaccine.2016.10.078_b0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fpubh.2015.00269","article-title":"Vaccines through centuries: major cornerstones of global health","volume":"3","author":"Hajj Hussein","year":"2015","journal-title":"Front Public Health"},{"key":"10.1016\/j.vaccine.2016.10.078_b0015","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2471\/BLT.07.040089","article-title":"Vaccination greatly reduces disease, disability, death and inequity worldwide","volume":"86","author":"Andre","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2016.10.078_b0020","unstructured":"World Health Organization. Immunization coverage. <http:\/\/www.who.int\/mediacentre\/factsheets\/fs378\/en\/> [accessed 21.04.16]."},{"key":"10.1016\/j.vaccine.2016.10.078_b0025","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.15585\/mmwr.mm6444a5","article-title":"Global routine vaccination coverage, 2014","volume":"64","author":"Subaiya","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.10.078_b0030","doi-asserted-by":"crossref","first-page":"6700","DOI":"10.1016\/j.vaccine.2016.10.042","article-title":"Vaccine hesitancy and healthcare providers","volume":"34","author":"Paterson","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.078_b0035","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3109\/00365548.2011.582247","article-title":"Vaccine herd effect","volume":"43","author":"Kim","year":"2011","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.078_b0040","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1016\/j.vaccine.2016.10.025","article-title":"Vaccine impact: benefits for human health","volume":"34","author":"Doherty","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.078_b0045","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1080\/21645515.2015.1052196","article-title":"Dissecting the indirect effects caused by vaccines into the basic elements","volume":"11","author":"Scarbrough Lefebvre","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.10.078_b0050","unstructured":"World Health Organization. Vaccine introduction guidelines. Adding a vaccine to a national immunization programme: decision and implementation. WHO\/IVB\/05.18. Geneva, Switzerland; 2005."},{"key":"10.1016\/j.vaccine.2016.10.078_b0055","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1016\/j.vaccine.2016.11.015","article-title":"Vaccination of special populations: protecting the vulnerable","volume":"34","author":"Doherty","year":"2016","journal-title":"Vaccine"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2016.10.078_b0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/1469-0691.12537","article-title":"Lifelong vaccination as a key disease-prevention strategy","volume":"20","author":"Bonanni","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2016.10.078_b0065","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0264-410X(98)00286-2","article-title":"Universal hepatitis B immunization: infant, and infant plus adolescent immunization","volume":"16","author":"Bonanni","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.078_b0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jcv.2005.09.009","article-title":"Increasing incidence of mumps in Scotland: options for reducing transmission","volume":"35","author":"Donaghy","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2016.10.078_b0075","first-page":"1","article-title":"Mass vaccination: when and why","volume":"304","author":"Heymann","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2016.10.078_b0080","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.4161\/21645515.2014.981115","article-title":"The polio endgame","volume":"10","author":"Minor","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.10.078_b0085","first-page":"40","article-title":"The mathematics of vaccination","volume":"40","author":"Keeling","year":"2013","journal-title":"Math Today"},{"key":"10.1016\/j.vaccine.2016.10.078_b0090","unstructured":"Indian Academy of Pediatrics. IAP guidebook on immunization: licensing procedure and inclusion of a vaccine in the National Immunization Program (NIP) of a country. <http:\/\/www.iapcoi.com\/hp\/pdf\/IAP%20GUIDE%20BOOK%20ON%20IMMUNIZATION%20LICENSING%20PROCEDURE%20AND%20INCLUSION%20OF%20A%20VACCINE%20IN%20THE%20NATIONAL%20IMMUNIZATION%20PROGRAM%20(NIP)%20OF%20A%20COUNTRY.pdf> [accessed 21.04.16]."},{"key":"10.1016\/j.vaccine.2016.10.078_b0095","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1016\/j.vaccine.2012.08.029","article-title":"The impact of new vaccine introduction on immunization and health systems: a review of the published literature","volume":"30","author":"Hyde","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.078_b0100","unstructured":"International Agency for Research on Cancer. Cervical cancer. Estimated incidence, mortality and prevalence worldwide in 2012. <http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_cancer.aspx> [accessed 21.04.16]."},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2016.10.078_b0105","doi-asserted-by":"crossref","first-page":"F47","DOI":"10.1016\/j.vaccine.2012.06.066","article-title":"Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa","volume":"31","author":"Sankaranarayanan","year":"2013","journal-title":"Vaccine"},{"issue":"Suppl 11","key":"10.1016\/j.vaccine.2016.10.078_b0110","doi-asserted-by":"crossref","first-page":"L96","DOI":"10.1016\/j.vaccine.2008.05.062","article-title":"Recommendations for cervical cancer prevention in Latin America and the Caribbean","volume":"26","author":"Mu\u00f1oz","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl 8","key":"10.1016\/j.vaccine.2016.10.078_b0115","doi-asserted-by":"crossref","first-page":"I1","DOI":"10.1016\/j.vaccine.2013.07.026","article-title":"Comprehensive control of human papillomavirus infections and related diseases","volume":"31","author":"Bosch","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.078_b0120","doi-asserted-by":"crossref","DOI":"10.2471\/BLT.11.089862","article-title":"Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries","volume":"89","author":"LaMontagne","year":"2011","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2016.10.078_b0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pcl.2015.08.004","article-title":"Global delivery of human papillomavirus vaccines","volume":"63","author":"Wigle","year":"2016","journal-title":"Pediatr Clin North Am"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2016.10.078_b0130","doi-asserted-by":"crossref","first-page":"F192","DOI":"10.1016\/j.vaccine.2012.06.075","article-title":"Implementation of human papillomavirus immunization in the developing world","volume":"30","author":"Kane","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.078_b0135","unstructured":"GAVI Alliance. Immunization financing toolkit. A resource for policy-makers and program managers. <http:\/\/www.gavi.org\/library\/publications\/other-publishers\/> [accessed 21.04.16]."},{"key":"10.1016\/j.vaccine.2016.10.078_b0140","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1016\/j.vaccine.2015.10.022","article-title":"A cost comparison of introducing and delivering pneumococcal, rotavirus and human papillomavirus vaccines in Rwanda","volume":"33","author":"Ngabo","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.078_b0145","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/icb.2009.15","article-title":"Vaccines, global health and social equity","volume":"87","author":"Levine","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2016.10.078_b0150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/hpm.822","article-title":"Regional group purchasing of vaccines: review of the Pan American Health Organization EPI revolving fund and the Gulf Cooperation Council group purchasing program","volume":"21","author":"DeRoeck","year":"2006","journal-title":"Int J Health Plann Manage"},{"key":"10.1016\/j.vaccine.2016.10.078_b0155","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1016\/j.vaccine.2015.10.055","article-title":"The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations","volume":"33","author":"S\u00e1fadi","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.078_b0160","unstructured":"Bhutan Health Trust Fund. Bhutan Health Trust Fund. Towards sustaining primary health care services in Bhutan. <http:\/\/www.bhtf.bt\/> [accessed 21.04.16]."},{"key":"10.1016\/j.vaccine.2016.10.078_b0165","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/vaccines1030204","article-title":"Sustaining vaccine confidence in the 21st century","volume":"1","author":"Hardt","year":"2013","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2016.10.078_b0170","first-page":"235","article-title":"Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut\/Stand: Juli 2004","volume":"30","author":"Koch-Institut","year":"2004","journal-title":"Epidemiologisches Bull"},{"key":"10.1016\/j.vaccine.2016.10.078_b0175","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.13.19530-en","article-title":"Impact of the routine varicella vaccination programme on varicella epidemiology in Germany","volume":"15","author":"Siedler","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2016.10.078_b0180","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.vaccine.2009.10.086","article-title":"Comparative varicella vaccine effectiveness during outbreaks in day-care centres","volume":"28","author":"Spackova","year":"2010","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2016.10.078_b0185","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/522145","article-title":"Varicella vaccine effectiveness in the US vaccination program: a review","volume":"197","author":"Seward","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.078_b0190","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2016.10.078_b0195","first-page":"279","article-title":"Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut\/Stand: Juli 2009","volume":"30","author":"Koch-Institut","year":"2009","journal-title":"Epidemiologisches Bull"},{"key":"10.1016\/j.vaccine.2016.10.078_b0200","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1471-2334-13-303","article-title":"Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006\u20132011","volume":"13","author":"Streng","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2016.10.078_b0205","doi-asserted-by":"crossref","first-page":"A28","DOI":"10.1016\/j.vaccine.2014.10.090","article-title":"Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group\u2019s experience","volume":"33","author":"Jauregui","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.078_b0210","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1177\/003335490712200613","article-title":"A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO\u2019s ProVac initiative","volume":"122","author":"Andrus","year":"2007","journal-title":"Public Health Rep"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2016.10.078_b0215","doi-asserted-by":"crossref","first-page":"A26","DOI":"10.1016\/j.vaccine.2010.02.028","article-title":"The Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) initiative: a country-driven, multi-partner program to support evidence-based decision making","volume":"28","author":"Senouci","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.078_b0220","unstructured":"Agence de M\u00e9decine Pr\u00e9ventive. Health Policy and Institutional Development. <http:\/\/amp-vaccinology.org\/HPID> [accessed 21.04.16]."},{"key":"10.1016\/j.vaccine.2016.10.078_b0225","unstructured":"Health Policy and Institutional Development (HPID) unit at the AMP. NITAG Resource Center. <http:\/\/www.nitag-resource.org\/who-we-are> [accessed 26.08.16]."},{"key":"10.1016\/j.vaccine.2016.10.078_b0230","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.vaccine.2014.12.026","article-title":"Supporting countries in establishing and strengthening NITAGs: lessons learned from 5 years of the SIVAC initiative","volume":"33","author":"Adjagba","year":"2015","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2016.10.078_b0235","doi-asserted-by":"crossref","first-page":"A76","DOI":"10.1016\/j.vaccine.2010.02.038","article-title":"The Australian model of immunization advice and vaccine funding","volume":"28","author":"Nolan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.078_b0240","unstructured":"European Centre for Disease Prevention and Control (ECDC). Current practices in immunisation policymaking in European countries. <http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/Current-practices-on-immunisation-policymaking-processes-Mar-2015.pdf> [accessed 26.08.16]."},{"key":"10.1016\/j.vaccine.2016.10.078_b0245","first-page":"129","article-title":"Pneumococcal vaccines. WHO position paper - 2012","volume":"87","author":"World Health Organization","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2016.10.078_b0250","first-page":"E13","article-title":"Influenza vaccination in high-risk groups: a revision of existing guidelines and rationale for an evidence-based preventive strategy","volume":"57","author":"Costantino","year":"2016","journal-title":"J Prev Med Hyg"},{"key":"10.1016\/j.vaccine.2016.10.078_b0255","unstructured":"World Health Organization. South African Vaccination and Immunisation Centre (SAVIC). <http:\/\/www.who.int\/vaccine_safety\/initiative\/communication\/network\/SAVIC\/en\/> [accessed 26.08.16]."},{"key":"10.1016\/j.vaccine.2016.10.078_b0260","unstructured":"University of Antwerp. Network for Education and Support in Immunisation. <http:\/\/www.nesi.be\/> [accessed 26.08.16]."},{"key":"10.1016\/j.vaccine.2016.10.078_b0265","unstructured":"University of Cape Town. Vaccines for Africa Initiative. <http:\/\/www.vacfa.uct.ac.za\/> [accessed 26.08.16]."},{"key":"10.1016\/j.vaccine.2016.10.078_b0270","unstructured":"International Vaccine Institute. About IVI. <http:\/\/www.ivi.org\/web\/www\/home> [accessed 26.08.16]."},{"key":"10.1016\/j.vaccine.2016.10.078_b0275","unstructured":"ECAVI. East Africa Centre for Vaccines and Immunization (ECAVI). <http:\/\/www.e-cavi.com\/> [accessed 26.08.16]."},{"key":"10.1016\/j.vaccine.2016.10.078_b0280","unstructured":"Network for Education and Support in Immunisation. HPV workshop: \u2019Implementing HPV vaccination in Africa: opportunities for strengthening adolescent health\u2019. <http:\/\/www.nesi.be\/area-of-work\/training\/3\/2016#303> [accessed 26.08.16]."},{"key":"10.1016\/j.vaccine.2016.10.078_b0285","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1016\/j.vaccine.2015.06.094","article-title":"Inaugural conference of the International Association of Immunization Managers (IAIM), Istanbul Turkey, 3\u20134 March 2015","volume":"33","author":"Carrasco","year":"2015","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2016.10.078_b0290","doi-asserted-by":"crossref","first-page":"B97","DOI":"10.1016\/j.vaccine.2012.12.040","article-title":"Civil society organizations, the implementing partners of the Global Vaccine Action Plan","volume":"31","author":"Thacker","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.078_b0295","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1016\/j.vaccine.2014.07.076","article-title":"Experiences with provider and parental attitudes and practices regarding the administration of multiple injections during infant vaccination visits: lessons for vaccine introduction","volume":"32","author":"Wallace","year":"2014","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2016.10.078_b0300","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1093\/infdis\/jit588","article-title":"Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil\u2019s National Immunization Program","volume":"210","author":"Domingues","year":"2014","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2016.10.078_b0305","doi-asserted-by":"crossref","first-page":"S571","DOI":"10.1093\/infdis\/jir472","article-title":"Elimination of rubella and congenital rubella syndrome in the Americas","volume":"204","author":"Castillo-Sol\u00f3rzano","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.078_b0310","doi-asserted-by":"crossref","first-page":"e0139680","DOI":"10.1371\/journal.pone.0139680","article-title":"Missed opportunities for measles, mumps, and rubella (MMR) immunization in Mesoamerica: potential impact on coverage and days at risk","volume":"10","author":"Mokdad","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.10.078_b0315","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2471\/BLT.08.059220","article-title":"Hepatitis B control by 2012 in the WHO Western Pacific Region: rationale and implications","volume":"87","author":"Rani","year":"2009","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2016.10.078_b0320","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(14)60686-3","article-title":"Effectiveness of maternal pertussis vaccination in England: an observational study","volume":"384","author":"Amirthalingam","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.10.078_b0325","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1542\/peds.2008-0813","article-title":"Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit","volume":"122","author":"Dylag","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.10.078_b0330","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1586\/14760584.2014.951036","article-title":"A review of the indirect protection of younger children and the elderly through a mass influenza vaccination program in Japan","volume":"13","author":"Sugaya","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.10.078_b0335","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ypmed.2013.05.021","article-title":"Trends in influenza vaccine coverage among primary healthcare workers in Spain, 2008\u20132011","volume":"57","author":"Castilla","year":"2013","journal-title":"Prev Med"},{"key":"10.1016\/j.vaccine.2016.10.078_b0340","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1016\/j.vaccine.2012.05.007","article-title":"Uptake of pandemic influenza (H1N1)-2009 vaccines in Brazil, 2010","volume":"30","author":"Domingues","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.078_b0345","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.vaccine.2011.12.123","article-title":"Measles control in Sub-Saharan Africa: South Africa as a case study","volume":"30","author":"Verguet","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.078_b0350","unstructured":"Public Health England. Human papillomavirus (HPV) vaccine coverage in England, 2008\/09 to 2013\/14. A review of the full six years of the three-dose schedule. <https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/412264\/HPV_Vaccine_Coverage_in_England_200809_to_201314.pdf> [accessed 21.04.16]."},{"key":"10.1016\/j.vaccine.2016.10.078_b0355","doi-asserted-by":"crossref","first-page":"614","DOI":"10.5694\/mja13.10272","article-title":"Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach","volume":"199","author":"Brotherton","year":"2013","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2016.10.078_b0360","doi-asserted-by":"crossref","first-page":"784","DOI":"10.15585\/mmwr.mm6429a3","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years\u2013United States, 2014","volume":"64","author":"Reagan-Steiner","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.10.078_b0365","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.vaccine.2013.02.047","article-title":"A systematic review of rubella vaccination strategies implemented in the Americas: impact on the incidence and seroprevalence rates of rubella and congenital rubella syndrome","volume":"31","author":"Mongua-Rodriguez","year":"2013","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2016.10.078_b0370","first-page":"S323","article-title":"Immunization and equity in the Regional Initiative of the Mesoamerican Health Initiative","volume":"53","author":"Franco-Paredes","year":"2011","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.vaccine.2016.10.078_b0375","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/ije\/dyi206","article-title":"A mathematical model to estimate global hepatitis B disease burden and vaccination impact","volume":"34","author":"Goldstein","year":"2005","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2016.10.078_b0380","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/j.jhep.2015.01.018","article-title":"Strategies to control hepatitis B: public policy, epidemiology, vaccine and drugs","volume":"62","author":"Locarnini","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2016.10.078_b0385","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1016\/j.vaccine.2014.02.093","article-title":"Are we there yet? Assessing achievement of vaccine-preventable disease goals in WHO\u2019s Western Pacific Region","volume":"32","author":"Hennessey","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.078_b0390","doi-asserted-by":"crossref","first-page":"e26282","DOI":"10.1371\/journal.pone.0026282","article-title":"Influenza-related mortality trends in Japanese and American seniors: evidence for the indirect mortality benefits of vaccinating schoolchildren","volume":"6","author":"Charu","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.10.078_b0395","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1086\/432938","article-title":"Mass vaccination of schoolchildren against influenza and its impact on the influenza-associated mortality rate among children in Japan","volume":"41","author":"Sugaya","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.078_b0400","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/archdischild-2012-302968","article-title":"Strategies to control pertussis in infants","volume":"98","author":"Amirthalingam","year":"2013","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2016.10.078_b0405","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.inf.0000435503.44620.74","article-title":"Prospective nationwide surveillance of hospitalizations due to pertussis in children, 2006\u20132010","volume":"33","author":"Heininger","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.10.078_b0410","doi-asserted-by":"crossref","first-page":"e1475","DOI":"10.1542\/peds.2014-3925","article-title":"Strategies to decrease pertussis transmission to infants","volume":"135","author":"Forsyth","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.10.078_b0415","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jinf.2016.04.012","article-title":"Cost-effectiveness and programmatic benefits of maternal vaccination against pertussis in England","volume":"73","author":"van Hoek","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2016.10.078_b0420","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1080\/21645515.2016.1168953","article-title":"School-located vaccination for adolescents: past, present, and future and implications for HPV vaccine delivery","volume":"12","author":"Middleman","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2016.10.078_b0425","doi-asserted-by":"crossref","first-page":"S451","DOI":"10.1093\/cid\/civ493","article-title":"Communication challenges during the development and introduction of a new meningococcal vaccine in Africa","volume":"61","author":"Berlier","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.078_b0430","first-page":"157","article-title":"Maternal satisfaction about childhood immunization in primary health care center, Egypt","volume":"18","author":"El Gammal","year":"2014","journal-title":"Pan Afr Med J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16310301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16310301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T16:45:39Z","timestamp":1657817139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16310301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":86,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0264410X16310301"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.078","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine strategies: Optimising outcomes","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}